Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution
Nenhuma Miniatura disponível
Data
2016-02-01
Autores
Sadeghi, Zhina
Isariyawongse, Justin
Kavran, Michael
Izgi, Kenan
Marini, Gabriela [UNESP]
Molter, Joseph
Daneshgari, Firouz
Flask, Chris A.
Caplan, Arnold
Hijaz, Adonis
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Introduction and hypothesis: We evaluated the potential role of human mesenchymal stem cells (hMSCs) in improvement of urinary continence following birth-trauma injury. Methods: Human MSCs were injected periurethrally or systemically into rats immediately after vaginal distention (VD) (n = 90). Control groups were non-VD (uninjured/untreated, n = 15), local or systemic saline (injection/control, n = 90), and dermofibroblast (cell therapy/control, n = 90). Leak-point pressure (LPP) was measured 4, 10, and 14 days later. Urethras were morphometrically evaluated. In another sets of VD and non-VD rats, the fate of periurethrally injected hMSC, biodistribution, and in vivo viability was studied using human Alu genomic repeat staining, PKH26 labeling, and luciferase-expression labeling, respectively. Results: Saline- and dermofibroblast-treated control rats demonstrated lower LPP than non-VD controls at days 4 and 14 (P < 0.01). LPP after systemic hMSC and periurethral hMSC treatment were comparable with non-VD controls at 4, 10, and 14 days (P > 0.05). Local saline controls demonstrated extensive urethral tissue bleeding. The connective tissue area/urethral section area proportion and vascular density were higher in the local hMSC- versus the saline-treated group at 4 and 14 days, respectively. No positive Alu-stained nuclei were observed in urethras at 4, 10, and 14 days. PKH26-labelled cells were found in all urethras at 2 and 24 h. Bioluminescence study showed increased luciferase expression from day 0 to 1 following hMSC injection. Conclusions: Human MSCs restored the continence mechanism with an immediate and sustained effect in the VD model, while saline and dermofibroblast therapy did not. Human MSCs remained at the site of periurethral injection for <7 days. We hypothesize that periurethral hMSC treatment improves vascular, connective tissue, and hemorrhage status of urethral tissues after acute VD injury.
Descrição
Palavras-chave
Birth-trauma injury, Mesenchymal stem cell, MSC biodistribution, Stem cell fate, Stress urinary incontinence
Como citar
International Urogynecology Journal, v. 27, n. 2, p. 291-300, 2016.